60 Degrees Pharmaceuticals, Inc. (SXTP) stock
SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3060% below fair value
$0.53+0.04 (+8.14%)
Close on Nov 17, 2026Market cap $1.88MP/E –Yield –
60 Degrees Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
60 Degrees Pharmaceuticals's price to sales ratio was 1.2× on Nov 11, 2026, against 4.6× a year earlier. Over the last 3 years it ranged from 1.2× to 10.0×, with a median of 3.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.2× | −1.0 |
| 2025 | Dec 31, 2025 | 2.2× | −2.7 |
| 2024 | Dec 31, 2024 | 4.9× | – |
See a number that looks wrong?